$276.22
3.901.43%
Last update: Nov 6, 7:51 PM
Johnson & Johnson (JNJ) Stock Price, Quote, News & History
JNJNYSE
Johnson & Johnson wins FDA accelerated approval for RYBREVANT FASPRO to treat recurrent or metastatic head and neck cancer.
You can purchase shares of Johnson & Johnson (NYSE:JNJ) through any online brokerage.
Other companies in Johnson & Johnson’s space includes: Eli Lilly and Co (NYSE:LLY), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).
Johnson & Johnson has a consensus price target of $265.13.
The stock price for Johnson & Johnson (NYSE: JNJ) is $276 last updated November 6, 2026 at 7:51 PM EST.
There are no upcoming dividends for Johnson & Johnson.
Johnson & Johnson does not have any upcoming earnings scheduled.
There is no upcoming split for Johnson & Johnson.
Johnson & Johnson is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...
